FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

54 hedge funds and large institutions have $62.7M invested in Fate Therapeutics in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 5 closing their positions.

Holders
54
Holders Change
+10
Holders Change %
+22.73%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
17
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RG
1
Redmile Group
California
$7.99M
2
KCM
2
Kingdon Capital Management
New York
$8.75M
3
BGA
3
Belmont Global Advisors
Texas
$556K
4
BCM
4
Bridgeway Capital Management
Texas
$757K
5
Millennium Management
5
Millennium Management
New York
$321K

Top Sellers

1
HCMT
1
Highland Capital Management (Texas)
Texas
$0
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$4.4M
3
GTC
3
Ghost Tree Capital
New York
$0
4
TC
4
TFS Capital
Pennsylvania
$110K
5
TCM
5
Tufton Capital Management
Maryland
$40K
Name Holding Trade Value Shares
Change 		Shares
Change %
DADC
51
D.A. Davidson & Co
Montana
$2K – – –
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
HCMT
53
Highland Capital Management (Texas)
Texas
– -$3.5M -657,097 Closed
GTC
54
Ghost Tree Capital
New York
– -$476K -89,231 Closed
SCM
55
Sterling Capital Management
North Carolina
– -$159K -29,823 Closed
EEG
56
E.E. Geduld
– -$53K -10,000 Closed
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
– -$1K -103 Closed
1 2
3